Product logins

Find logins to all Clarivate products below.

home   •  Research Reports  •  Disease Landscape and Forecast Insights

Acute Kidney Injury | Current Treatment | US | 2018

Login to access report north_east
Contact sales account_box

Acute kidney injury (AKI) is defined as functional or structural abnormalities of the kidneys that cause sudden impairment of fluid homeostasis, resulting in retention of metabolic products over a period of hours to days. Diagnosis of AKI is challenging. Sometimes the symptoms are not evident, and they can be fatal by the time they are noticeable. The disease is increasingly common and potentially a catastrophic complication in hospitalized patients. This content examines the management of AKI from the perspective of nephrologists and critical care physicians. It provides a detailed and expanded analysis on the causes of AKI, the utility of current diagnosis methods, AKI staging criteria, and the treatment of AKI (such as fluid management, continuous veno-venous hemofiltration, intermittent hemodialysis, N-acetylcysteine, prednisone, and sodium bicarbonate). In addition, it discusses how nephrologists and critical care physicians perceive future treatment of AKI.

QUESTIONS ANSWERED

  • What are the common underlying causes of AKI?
  • What are the comorbidities and risk factors associated with AKI?
  • What percentage of patients present with AKI versus develop it in the hospital?
  • What are the roles and utility of biomarkers in diagnosing AKI and assessing the efficacy of treatment?
  • What are the main challenges faced in the management of AKI?
  • How frequently do physicians use RIFLE, AKIN, and KDIGO guidelines for AKI?

PRODUCT DESCRIPTION

Current Treatment: Physician Insights provides physician insights on treatment dynamics, prescribing behavior, and drivers of brand use so that you can create specific messaging around these treatment dynamics in order to more effectively increase or defend your market position.

GEOGRAPHIES

United States

PRIMARY RESEARCH

Survey of 64 nephrologists and 36 critical care physicians in the United States.

KEY TREATMENTS COVERED

Intermittent hemodialysis, continuous veno-venous hemofiltration, fluid management, sodium bicarbonate, N-acetylcysteine, prednisone

Contact sales account_box
Login to access report north_east

Related Market Assessment Reports

Report
Amyotrophic Lateral Sclerosis – Landscape & Forecast – Niche & Rare Disease Landscape & Forecast (US/EU5)
Amyotrophic lateral sclerosis (ALS) is a disorder of the central nervous system characterized by motor neuron degeneration. ALS causes progressive weakness and atrophy of the muscles and loss of…
north_east
Report
Kidney Transplant – Current Treatment – Treatment Algorithms: Claims Data Analysis – Kidney Transplant (US)
Each year in the United States, thousands of patients with end-stage renal disease undergo a kidney transplant. To prevent rejection and maintain the new kidney’s functionality, patients must…
north_east
Report
Hyperkalemia – Current Treatment – Treatment Algorithms: Claims Data Analysis – Hyperkalemia (US)
Hyperkalemia is a potentially life-threatening condition characterized by a serum potassium concentration that exceeds 5.5 mEq/L. Despite various guidelines, a universally accepted consensus on the…
north_east
Report
Primary Biliary Cholangitis – Current Treatment – Treatment Algorithms: Claims Data Analysis – Primary Biliary Cholangitis (US)
Primary biliary cholangitis (PBC) is a rare autoimmune liver disease characterized by inflammation and progressive damage to intrahepatic bile ducts, leading to bile buildup, followed by…
north_east
Report
Squamous Cell Carcinoma of the Head and Neck – Landscape & Forecast – Disease Landscape & Forecast (G7)
Squamous cell carcinoma of the head and neck (SCCHN) is the seventh most commonly diagnosed cancer. It encompasses a spectrum of heterogeneous tumors originating at multiple sites in the head and…
north_east

Follow us

Contact us

Sales enquiries north_east
Customer service north_east
Support north_east